Steve Abrams > Hogan Lovells US LLP > Philadelphia, United States > Lawyer Profile

Hogan Lovells US LLP has made big progress in the equity sphere since the arrival of Richard Aftanas in 2020. Aftanas has given the firm much greater credibility in New York, an office that had been comparatively underweight compared to the firm’s other US offices. Historically the capital markets team has shown particular aptitude in the real estate, life sciences, healthcare and TMT fields, and now is spreading its industry breadth along with particular growth in cross-border offerings originating from Europe, Latin America and elsewhere. The team also benefits from the firm’s outstanding regulatory expertise. Philadelphia partner Steve Abrams co-heads the life sciences and healthcare group and has a fine record in equity offerings, while Washington DC’s David Bonser leads the global REIT practice and heads numerous equity issuances in this field.

In addition to ‘outstanding expertise with small to mid-sized public biotech and pharma companies’ Hogan Lovells US LLP is also able to act for international pharmaceuticals companies. The team’s regulatory capacity is a key factor in this, advising on FDA clearances and post-approval compliance. IP is another area of expertise, primarily in transactions where the team provides diligence support in major capital markets and M&A matters and acts on IP litigation. It also has a strong product liability offering led by Baltimore-based Lauren Colton, which advises on medical devices and pharmaceuticals. The Washington DC office is led by biologics risk evaluation expert Lynn Mehler, experienced biopharmaceutical startup advisor Philip Katz and Randy Prebula, who gives regulatory advice to medical device and technology companies. Also DC-based is David Fox, who is known for his Hatch Waxman compliance expertise. Philadelphia-based team leader Steve Abrams is known for transactional work. Also recommended are DC-based Anishiya Abrol and Philadephia-based Blake Wilson.